Literature DB >> 21067523

Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future.

Haruki Senoo1, Kiwamu Yoshikawa, Mayako Morii, Mitsutaka Miura, Katsuyuki Imai, Yoshihiro Mezaki.   

Abstract

HSCs (hepatic stellate cells) (also called vitamin A-storing cells, lipocytes, interstitial cells, fat-storing cells or Ito cells) exist in the space between parenchymal cells and liver sinusoidal endothelial cells of the hepatic lobule and store 50-80% of vitamin A in the whole body as retinyl palmitate in lipid droplets in the cytoplasm. In physiological conditions, these cells play pivotal roles in the regulation of vitamin A homoeostasis. In pathological conditions, such as hepatic fibrosis or liver cirrhosis, HSCs lose vitamin A and synthesize a large amount of extracellular matrix components including collagen, proteoglycan, glycosaminoglycan and adhesive glycoproteins. Morphology of these cells also changes from the star-shaped SCs (stellate cells) to that of fibroblasts or myofibroblasts. The hepatic SCs are now considered to be targets of therapy of hepatic fibrosis or liver cirrhosis. HSCs are activated by adhering to the parenchymal cells and lose stored vitamin A during hepatic regeneration. Vitamin A-storing cells exist in extrahepatic organs such as the pancreas, lungs, kidneys and intestines. Vitamin A-storing cells in the liver and extrahepatic organs form a cellular system. The research of the vitamin A-storing cells has developed and expanded vigorously. The past, present and future of the research of the vitamin A-storing cells (SCs) will be summarized and discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067523     DOI: 10.1042/CBI20100321

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  44 in total

1.  Endogenous Fluorescence Dissimilarity Assessment of Four Potential Biomarkers of Early Liver Fibrosis by Preservation Media Effect.

Authors:  Enoch Gutierrez-Herrera; Celia Sánchez-Pérez; Adolfo Perez-Garcia; Miguel A Padilla-Castaneda; Walfre Franco; Joselín Hernández-Ruiz
Journal:  J Fluoresc       Date:  2020-01-24       Impact factor: 2.217

2.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

Review 3.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

4.  Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.

Authors:  Virginia Hernández-Gea; Zahra Ghiassi-Nejad; Raphael Rozenfeld; Ronald Gordon; Maria Isabel Fiel; Zhenyu Yue; Mark J Czaja; Scott L Friedman
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

5.  Vitamins and non-alcoholic fatty liver disease: A Molecular Insight.

Authors:  Sana Raza; Archana Tewari; Sangam Rajak; Rohit A Sinha
Journal:  Liver Res       Date:  2021-04-04

6.  Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells.

Authors:  Sangeun Park; Soyoung Choi; Min-Goo Lee; Chaeseung Lim; Junseo Oh
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

7.  Vitamin A Supplementation Transiently Increases Retinol Concentrations in Extrahepatic Organs of Neonatal Rats Raised under Vitamin A-Marginal Conditions.

Authors:  Joanna K Hodges; Libo Tan; Michael H Green; A Catharine Ross
Journal:  J Nutr       Date:  2016-08-17       Impact factor: 4.798

8.  Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.

Authors:  Wendy A Harvey; Kimberly Jurgensen; Xinzhu Pu; Cheri L Lamb; Kenneth A Cornell; Reilly J Clark; Carolyn Klocke; Kristen A Mitchell
Journal:  Toxicology       Date:  2016-02-06       Impact factor: 4.221

9.  Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats.

Authors:  Xiaojing Zhu; Feng Zhang; Liang Zhou; Desong Kong; Li Chen; Yin Lu; Shizhong Zheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-21       Impact factor: 3.000

10.  Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.

Authors:  Bo-Lin Chen; Jie Peng; Qing-Fu Li; Min Yang; Yuan Wang; Wei Chen
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.